Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TSX/CRDL stock hub

TSX/CRDL has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TSX/CRDLis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

201.4M

Toronto Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TSX/CRDL

In the news

Latest news · TSX/CRDL

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROE-158.8

P25 -121.5P50 -40.9P75 0.5

ROIC-100

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TSX/CRDL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

153

Groups with data

Currency

CAD

Showing 153 of 153 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Employees	18
Enterprise value	CAD 180.1M
Exchange	Toronto Stock Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CA14161Y2006
Last refreshed	2026-05-10
Market cap	CAD 201.4M
Price	CAD 1.8
Price currency	CAD
Sector	Healthcare
Sic	2836
Symbol	tsx/CRDL
Website	https://www.cardiolrx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-16.79%
EV Earnings	-5.32x
EV/FCF	-7.54x
FCF yield	-11.86%
P/B ratio	11.26x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	CAD -33.8M
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Profit Per Employee	CAD -1.9M
ROA	-77.31
Roa5y	-53.9
ROCE	-191
ROE	-158.8
Roe5y	-97.2
ROIC	-100

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	21.64%
Cagr3y	30.49%
Cagr5y	-11.26%
EPS Growth Quarters	2
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	CAD 23.6M
Cash	CAD 21.4M
Current Assets	CAD 23.5M
Current Liabilities	CAD 5.7M
Debt	CAD 125,523
Debt Equity	CAD 0.01
Debt FCF	CAD -0.01
Equity	CAD 17.9M
Liabilities	CAD 5.7M
Long Term Assets	CAD 118,093
Long Term Liabilities	CAD 87,176
Net Cash	CAD 21.3M
Net Cash By Market Cap	CAD 10.57
Net Cash Growth	-30.01%
Net Debt Equity	CAD -1.19
Tangible Book Value	CAD 17.9M
Tangible Book Value Per Share	CAD 0.18
WACC	6.58

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.16
Net Working Capital	CAD -3.5M
Quick ratio	3.83
Working Capital	CAD 17.8M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-21.55%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	21.62%
200-day SMA	1.55
3Y total return	122.22%
50-day SMA	1.7
50-day SMA vs 200-day SMA	50over200
5Y total return	-44.95%
All Time High	8.49
All Time High Change	-78.8%
All Time High Date	2019-02-25
All Time Low	0.61
All Time Low Change	195.08%
All Time Low Date	2023-04-05
ATR	0.11
Beta	0.42
Beta1y	1.92
Beta2y	2.31
Ch YTD	37.41
High	1.82
High52	2.33
High52 Date	2026-04-22
High52ch	-22.75%
Low	1.76
Low52	1.23
Low52 Date	2026-03-20
Low52ch	46.94%
Ma50ch	6.13%
Price vs 200-day SMA	16.5%
RSI	48.28
RSI Monthly	50.32
RSI Weekly	56.84
Sharpe ratio	0.57x
Sortino ratio	0.96
Total Return	-21.55%
Tr YTD	37.41
Tr1m	-6.74%
Tr1w	-2.17%
Tr3m	31.39%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -34.3M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	96,489,056%
Net Borrowing	-55,376
Shares Insiders	3.05%
Shares Institutions	7.63%
Shares Out	111,872,084
Shares Qo Q	15.6%
Shares Yo Y	21.55%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -34.6M
Average Volume	118,956.95x
Bv Per Share	0.18
CAPEX	CAD -24,484
Ch1m	-6.74
Ch1w	-2.17
Ch1y	21.62
Ch3m	31.39
Ch3y	122.2
Ch5y	-44.95
Ch6m	28.57
Change	1.12%
Change From Open	-0.55
Close	1.78
Days Gap	1.69
Depreciation Amortization	37,999
Dollar Volume	60,222.6
Earnings Date	2026-05-14
EBIT	CAD -34.3M
EBITDA	CAD -34.3M
EPS	CAD -0.39
F Score	1
FCF	CAD -23.9M
FCF EV Yield	-13.26x
FCF Per Share	CAD -0.21
Financing CF	15,539,830
Fiscal Year End	December
Founded	2,017
Investing CF	-24,484
Is Primary Listing	1
Last Earnings Date	2025-11-12
Last Report Date	2025-12-31
Ma150	1.52
Ma150ch	18.34%
Ma20	1.91
Ma20ch	-5.56%
Net CF	-9,163,345
Next Earnings Date	2026-05-14
Open	1.81
Position In Range	66.67
Ppne	118,093
Price Date	2026-05-08
Ptbv Ratio	11.26
Relative Volume	0.28x
Share Based Comp	10,700,913
Tr6m	28.57%
Volume	33,457

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TSX/CRDL pay a dividend?

Capital-return profile for this ticker.

Performance

TSX/CRDL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TSX/CRDL?

Insider, institutional, and short-interest positioning.

Institutional ownership

+7.6%

Share of float held by funds and institutions

Insider ownership

+3.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+21.5%

Negative means the company is buying back shares.

Technical

TSX/CRDL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.3

Neutral momentum band

Price vs 200-day MA

+16.5%

50/200-day relationship not available

Beta (5Y)

0.42

Less volatile than the market

Sharpe ratio

0.57

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TSX/CRDL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsx/CRDL stock rating?

tsx/CRDL is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsx/CRDL analysis?

The full report lives at /stocks/tsx/CRDL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsx/CRDL?

The latest report frames tsx/CRDL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsx/CRDL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.